Japan to Begin Injecting New Self-Replicating ‘Replicon’ saRNA Vaccines Next Month

An exotic new technology will soon be injected into human bodies. Called ‘self-amplifying mRNA’, ‘saRNA’ and ‘replicon‘ vaccines, the novel injections developed by Arcturus Therapeutics and produced under the brand name ‘Kostaive’ which is distributed by pharmaceutical company Meiji Seika Pharma for ‘protection’ against the Covid virus are set to hit the bloodstreams of patients in October.